Hyperinsulinism: Clinical Trials

30 trials for Hyperinsulinism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 terminated. 30 Phase 2, 5 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 230Terminated 30
Phase 15Terminated 5
Phase 32Terminated 2

Follow Hyperinsulinism: new trials by email Literature Review of Hyperinsulinism trials Research Report on Hyperinsulinism

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
MitoQ (mitoquinol mesylate), Placebo - Lower Urinary Tract Symptoms, Overactive Bladder Syndrome
Phase 2TerminatedIman Al-Naggar, PhD202024-04-032026-05-01
A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM
ALN-KHK, Placebo - Type 2 Diabetes Mellitus (T2DM)
Phase 1 / Phase 2TerminatedAlnylam Pharmaceuticals492023-03-102025-05-07
Intranasal Insulin in Frontotemporal Dementia (FTD)
Novolin-R insulin - Frontotemporal Dementia, Behavioral Variant
Phase 2TerminatedHealthPartners Institute32019-09-092023-10-27
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
Humalog, Novolog, BC222 insulin lispro - Type 1 Diabetes Mellitus
Phase 2 / Phase 3TerminatedMassachusetts General Hospital202019-03-192022-12-09
Insulin Treatment in Diabetic Older People With Heart Failure.
Insulin - Heart Failure, Diabetes Mellitus, Type 2
Phase 2TerminatedMario Negri Institute for Pharmacological Research102018-11-082019-11-18
Neuro Biomarkers of Smoking Behavior
Novolin R - Smoking Cessation
Phase 2TerminatedUniversity of Illinois at Chicago42018-09-122021-03-02
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
Diazoxide, Placebo - Diabetes Mellitus, Type 2, Glucose, High Blood
Phase 2TerminatedMeredith Hawkins372018-06-122025-05-31
Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.
UCMSCs, BMMSCs, Placebo - Endothelial Dysfunction, Metabolic Syndrome
Phase 1 / Phase 2TerminatedJoshua M Hare142018-04-122022-11-08
Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk
Rosuvastatin Calcium, Placebo Oral Tablet, Coenzyme Q10 - Spinal Cord Injuries, Osteoporosis
Phase 2TerminatedDr. B. Catharine. Craven82018-02-262026-04-13
Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic Syndrome
PBI-4050, Placebo - Type 2 Diabetes Mellitus, Metabolic Syndrome
Phase 2TerminatedLiminal BioSciences Ltd.1042017-05-292020-12-08
Nitrite Infusion in Islet Cell Transplantation
Control, Pre-Isolation Infusion, Post-Isolation Infusion - Diabetes
Phase 2TerminatedUniversity of Alabama at Birmingham42017-05-072020-10-29
Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus
Mifepristone 600 mg daily, Placebo - Type 2 Diabetes Mellitus, Insulin Resistance
Phase 2TerminatedCharles Drew University of Medicine and Science82017-02-032023-05-18
Dose-response Study of Carduus Marianus in Centesimal Scale for Dyslipidemia in Climacteric Overweighed or Obese Women.
Carduus marianus 6cH, Carduus marianus 12cH, Carduus marianus 30cH - Dyslipidemia, Menopause
Phase 2TerminatedHospital Nacional Homeopático, Mexico622016-02-012019-02-28
The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects
Eritoran, D5W - Insulin Sensitivity
Phase 2TerminatedThe University of Texas Health Science Center at San Antonio152015-01-012020-03-04
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
Metformin, Placebo - Prostatic Neoplasm
Phase 2TerminatedAHS Cancer Control Alberta832014-09-012024-01-30
Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease
Roflumilast, Placebo - Chronic Obstructive Pulmonary Disease, Metabolic Syndrome
Phase 2TerminatedLaval University142013-02-012014-11-11
Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin
Metformin, Sugar pill - Insulin Resistance, Hypermetabolism
Phase 2 / Phase 3TerminatedThe University of Texas Medical Branch, Galveston362012-11-012019-11-29
The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance
Fish Oil (Omega-3 Fatty Acids) - Endothelial Dysfunction, Insulin Resistance
Phase 2TerminatedUniversity of California, San Francisco52011-09-012013-11-07
Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity
Metformin, Orlistat, Topiramate - Obesity, Metabolic Syndrome X
Phase 2TerminatedUniversity of Iowa1282011-03-012026-03-12
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Sodium Octanoate Breath Test - Metabolic Syndrome, Nonalcoholic Fatty Liver Disease
Phase 2TerminatedVirginia Commonwealth University612011-02-012015-07-28

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Insulin Resistance (19)  ·  Metabolic Syndrome (11)  ·  Diabetes Mellitus, Type 2 (9)  ·  Obesity (5)  ·  Diabetes Mellitus (3)  ·  Diabetes Mellitus, Type 1 (2)  ·  Dyslipidemias (2)  ·  Glucose Metabolism Disorders (2)  ·  Overweight (2)  ·  Autoimmune Diseases (1)  ·  Burns (1)  ·  Congenital Hyperinsulinism (1)  ·  Enterovirus Infections (1)  ·  Glucose Intolerance (1)  ·  Heart Failure (1)

Broader conditions

Nutritional and Metabolic Diseases (30)  ·  Metabolic Diseases (29)  ·  Glucose Metabolism Disorders (28)  ·  Endocrine System Diseases (12)  ·  Insulin Resistance (10)  ·  Diabetes Mellitus (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (7)  ·  Body Weight (6)  ·  Cardiovascular Diseases (5)  ·  Nutrition Disorders (5)  ·  Overnutrition (5)  ·  Vascular Diseases (4)  ·  Nervous System Diseases (3)

Interventions

Insulin (5)  ·  Metformin (3)  ·  Bosentan (1)  ·  Calcium Carbonate (1)  ·  Clomiphene (1)  ·  Cyclosporine (1)  ·  Diazoxide (1)  ·  Diet (1)  ·  E5564 (1)  ·  Exercise (1)  ·  Fatty Acids, Omega-3 (1)  ·  Fish Oils (1)  ·  Glucagon-Like Peptide 1 (1)  ·  Glycemic Control (1)  ·  Incretins (1)

Sponsors

AHS Cancer Control Alberta (1)  ·  Albert Einstein College of Medicine (1)  ·  Alnylam Pharmaceuticals (1)  ·  Charles Drew University of Medicine and Science (1)  ·  Diva De Leon (1)  ·  Dr. B. Catharine. Craven (1)  ·  GlaxoSmithKline (1)  ·  HealthPartners Institute (1)  ·  Hospital Nacional Homeopático, Mexico (1)  ·  Iman Al-Naggar, PhD (1)  ·  Joshua M Hare (1)  ·  Laval University (1)  ·  Liminal BioSciences Ltd. (1)  ·  Mario Negri Institute for Pharmacological Research (1)  ·  Massachusetts General Hospital (1)

Countries

United States (21)  ·  Canada (5)  ·  Austria (1)  ·  Brazil (1)  ·  Italy (1)  ·  Mexico (1)  ·  Norway (1)  ·  Spain (1)

Top investigators

Ajna Hamidovic, PharmD, MS (1)  ·  Albert Feliu, MD PhD (1)  ·  Arun J. Sanyal, M.D. (1)  ·  B. Catharine Craven, BA, MD, FRCPC, MSc (1)  ·  Blair Smith, MD (1)  ·  Bruno Geloneze, MD, PhD (1)  ·  Daniel T Stein, MD (1)  ·  David N Herndon, MD (1)  ·  Diva D De Leon, MD MSCE (1)  ·  Emma del Carmen Macias-Cortes, PhD (1)  ·  Gary L Pierce, PhD (1)  ·  Giovanni Cizza, M.D. (1)  ·  Gloria Bueno, MD, PhD (1)

Results publications

PMID 19475464, PMID 21799479, PMID 22689694, PMID 23483886, PMID 23734252, PMID 24482677, PMID 36066991, PMID 39952695, PMID 41388232

NIH funding

2008 (1), 2016 (1), 2018 (1), P30AG067988 (1), R01DK061644 (1), R01DK069861 (1)